Concepedia

Zhiying Zheng

ZZ

Statistics

Publications

5

Citations

561

H-Index

5

Active since

2022

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Nanjing Medical University

Jiangsu Province Hospital

Tianjin University of Traditional Chinese Medicine

Southeast University

Zhiying Zheng is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and programmed cell death protein 1 (pd-1) pathway.

Publications per year

2022–2023

5

Publications

5

Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing

Xiaopei Hao, Zhiying Zheng, Hanyuan Liu et al. · Redox Biology · 2022 · 303 citations · Full text

, , +17

MGP promotes CD8<sup>+</sup> T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer

Dawei Rong, Guangshun Sun, Zhiying Zheng et al. · International Journal of Biological Sciences · 2022 · 118 citations · Full text

, , +17

CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ

Xiaopei Hao, Yao Zhang, Xiaoli Shi et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 104 citations · Full text

, , +16

GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway

Dawei Rong, Yuliang Wang, Li Liu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 20 citations · Full text

, , +17

Over-Expression of GUSB Leads to Primary Resistance of Anti-PD1 Therapy in Hepatocellular Carcinoma

Xiangyi Kong, Zhiying Zheng, Guoxin Song et al. · Frontiers in Immunology · 2022 · 16 citations · Full text

, , +17

1–5 of 5